...
首页> 外文期刊>Frontiers in Immunology >Antibodies Reactive to Commensal Streptococcus mitis Show Cross-Reactivity With Virulent Streptococcus pneumoniae Serotypes
【24h】

Antibodies Reactive to Commensal Streptococcus mitis Show Cross-Reactivity With Virulent Streptococcus pneumoniae Serotypes

机译:与普通链球菌有反应性的抗体显示与强毒肺炎链球菌血清型的交叉反应

获取原文

摘要

Current vaccines against Streptococcus pneumoniae , a bacterial species that afflicts people by causing a wide spectrum of diseases, do not protect against all pneumococcal serotypes. Thus, alternative vaccines to fight pneumococcal infections that target common proteins are under investigation. One promising strategy is to take advantage of immune cross-reactivity between commensal and pathogenic microbes for cross-protection. In this study, we examined the antibody-mediated cross-reactivity between S. pneumoniae and Streptococcus mitis , a commensal species closely related to S. pneumoniae . Western blot analysis showed that rabbit antisera raised against S. mitis reacted with multiple proteins of virulent S. pneumoniae strains (6B, TIGR4, and D39). Rabbit anti- S. pneumoniae IgG antibodies also showed binding to S. mitis antigens. Incubation of rabbit antisera raised against S. mitis with heterologous or homologous bacterial lysates resulted in marked inhibition of the developments of bands in the Western blots. Furthermore, plasma IgG antibodies from adult human volunteers intranasally inoculated with S. pneumoniae 6B revealed enhanced S. mitis -specific IgG titers compared with the pre-inoculation samples. Using an on-chip protein microarray representing a number of selected membrane and extracellular S. pneumoniae proteins, we identified choline-binding protein D (CbpD), cell division protein (FtsH), and manganese ABC transporter or manganese-binding adhesion lipoprotein (PsaA) as common targets of the rabbit IgG antibodies raised against S. mitis or S. pneumoniae . Cumulatively, these findings provide evidence on the antibody-mediated cross-reactivity of proteins from S. mitis and S. pneumoniae , which may have implications for development of effective and wide-range pneumococcal vaccines.
机译:当前针对肺炎链球菌的疫苗,这种细菌通过引起广泛的疾病而困扰着人们,不能预防所有的肺炎球菌血清型。因此,正在研究替代针对普通蛋白的肺炎球菌感染的替代疫苗。一种有希望的策略是利用共生和病原微生物之间的免疫交叉反应进行交叉保护。在这项研究中,我们检查了肺炎链球菌和链球菌性关节炎(一种与肺炎链球菌密切相关的共生物种)之间的抗体介导的交叉反应性。蛋白质印迹分析表明,针对抗链球菌的兔抗血清与强毒的肺炎链球菌菌株(6B,TIGR4和D39)的多种蛋白质反应。兔抗肺炎链球菌IgG抗体也显示出与微生物链球菌抗原的结合。用异源或同源细菌裂解物孵育针对抗链球菌的兔抗血清,可显着抑制蛋白质印迹中条带的形成。此外,与接种前的样品相比,鼻内接种肺炎链球菌6B的成年人类志愿者的血浆IgG抗体显示出增强的链球菌特异性IgG滴度。使用代表许多选定的膜和细胞外肺炎链球菌蛋白的芯片蛋白质微阵列,我们鉴定了胆碱结合蛋白D(CbpD),细胞分裂蛋白(FtsH)和锰ABC转运蛋白或锰结合粘附脂蛋白(PsaA )作为兔抗微生物链球菌或肺炎链球菌的IgG抗体的共同目标。累积地,这些发现提供了关于来自链球菌和肺炎链球菌的蛋白质的抗体介导的交叉反应的证据,这可能对开发有效的大范围肺炎球菌疫苗有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号